Renal Denervation Update From the International Sympathetic Nervous System Summit: JACC State-of-the-Art Review

Area of Science:

• Cardiovascular Medicine
• Nephrology
• Interventional Cardiology

Background:

• Recent studies show renal denervation effectively lowers blood pressure in hypertensive patients.
• Improvements in trial design and patient selection contribute to positive outcomes.
• Significant variability in patient response to renal denervation persists.

Purpose of the Study:

• To convene experts to discuss the current evidence and future directions for renal denervation.
• To address challenges in understanding and optimizing renal denervation therapy.
• To guide the clinical application of renal denervation for hypertension.

Main Methods:

• Review of recent clinical trials on renal denervation.
• Expert discussions on neural interplay, procedural techniques, and outcome monitoring.
• Synthesis of evidence from experimental and clinical research.

Main Results:

• Demonstrated significant reduction in ambulatory blood pressure in multiple studies.
• Highlighted the impact of improved trial design and patient selection.
• Acknowledged the persistent challenge of inter-patient variability in response.

Conclusions:

• Renal denervation is a promising treatment for hypertension, with recent studies showing efficacy.
• Addressing response variability is crucial for optimizing clinical use.
• Further tailored research is essential to establish renal denervation's role in hypertension management.